Milestone Pharmaceuticals opened higher at $0.69, compared with its previous close of $0.66. In the last trading session, the stock traded between $0.67 and $0.71. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Milestone Pharmaceuticals is now worth
$ 11.64
Resulting in a loss of
$ 88.36 (88.36%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 4 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.01 (-1.54%)
Day High
$0.71
Day Low
$0.67
Day Open
$0.69
Prev Close
$0.66
Volume
10,34,237
1W Return
-16.30%
1M Return
-19.01%
3M Return
-48.05%
6M Return
-65.68%
1Y Return
-65.86%
Fundamentals
Market Cap ($ Mn)
81
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-
ROCE
-93.80%
EPS (TTM)
$-0.23
Investment Returns
1 Week
-16.30%
1 Month
-19.01%
3 Months
-48.05%
6 Months
-65.68%
9 Months
-64.18%
Financials
Quarterly
All values in $ Mn
0.0
Mar 25
0.0
Jun 25
0.0
Sep 25
1.5
Dec 25
0.2
Mar 26
0.6
Jun 26
Updates
4Nov
Milestone Pharmaceuticals grants 33,000 stock options to new hire
Milestone Pharmaceuticals granted 33,000 stock options to a new employee. Exercise price set at $0.72 per share, equal to the closing price on November 2, 2026. Options vest over four years with 25% cliff vesting after one year. Grant complies with Nasdaq Listing Rule 5635(c)(4) for inducement awards.
9 days ago
12Aug
Milestone Pharmaceuticals Q2 Results: Net loss widens to $28.6M
Milestone Pharmaceuticals reported a Q2 2026 net loss of $28.6 million, widening from $13.0 million in the prior year due to elevated SG&A costs from the CARDAMYST launch. Product revenues hit $0.6 million with over 800 prescribers adopting the therapy. Cash reserves stand at $170.6 million, providing runway into H2 2027.
3mo ago
3Jul
Milestone Pharmaceuticals grants 288,000 options to new hires
Milestone Pharmaceuticals Inc. granted 288,000 options to six new employees at $1.32 per share under its 2021 Inducement Plan. The options vest over four years, with 25% vesting after one year and the remainder in monthly installments. The grants comply with Nasdaq Listing Rule 5635(c)(4) for hiring inducements.
